MMTC Micro Imaging Technology Inc (CE)

Micro Imaging Technology Inc. (OTCBB:MMTC), formerly Electropure Inc. ("ELTP"), announced that the NASD, effective Friday, June 10, 2006, will quote the company's common stock on the Over-the-Counter Bulletin Board. About Micro Imaging Technology: The company has developed and patented a laser-based technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is non-biological and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis. MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella Staphylococcus aureus, Shigella and other pathogenic bacteria. The identification process has been verified by North American Science Associates Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The Test Report, in the company's opinion, demonstrated the accuracy, speed and efficiency of the MIT system over conventional processes and is available from the company. This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.